RT Journal Article
SR Electronic
T1 Costs of hand hygiene for all in household settings - estimating the price tag for the 46 least developed countries
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2021.08.16.21262011
DO 10.1101/2021.08.16.21262011
A1 Ross, Ian
A1 Mills, Joanna Esteves
A1 Slaymaker, Tom
A1 Johnston, Richard
A1 Hutton, Guy
A1 Dreibelbis, Robert
A1 Montgomery, Maggie
YR 2021
UL http://medrxiv.org/content/early/2021/09/04/2021.08.16.21262011.abstract
AB Introduction Domestic hand hygiene could prevent over 500,000 attributable deaths per year, but 6 in 10 people in least developed countries (LDCs) do not have a handwashing facility with soap and water available at home. We estimated the economic costs of universal access to basic hand hygiene services in household settings in 46 LDCs.Methods Our model combines quantities of households with no handwashing facility (HWF) and prices of promotion campaigns, HWFs, soap, and water. For quantities, we used estimates from the WHO/UNICEF Joint Monitoring Programme. For prices, we collated data from recent impact evaluations and electronic searches. Accounting for inflation and purchasing power, we calculated costs over 2021-2030, and estimated total cost probabilistically using Monte Carlo simulation.Results An estimated US$ 12.2 - 15.3 billion over 10 years is needed for universal hand hygiene in household settings in 46 LDCs. The average annual cost of hand hygiene promotion is $334 million (24% of annual total), with a further $233 million for ‘top-up’ promotion (17%). Together, these promotion costs represent $0.47 annually per head of LDC population. The annual cost of HWFs, a purpose-built drum with tap and stand, is $174 million (13%). The annual cost of soap is $497 million (36%), and water $127 million (9%).Conclusion The annual cost of behaviour change promotion to those with no handwashing facility represents 4.7% of median government health expenditure in LDCs, and 1% of their annual aid receipts. These costs could be covered by mobilising resources from across government and partners, and could be reduced by harnessing economies of scale and integrating hand hygiene with other behaviour change campaigns where appropriate. Innovation is required to make soap more affordable and available for the poorest households.What is already known?Understanding resource requirements is important for planning, but data on the costs of improving domestic hand hygiene are scarce.While a 2016 study estimated the global cost of drinking water, sanitation and hygiene, it did not report hygiene-specific estimates of recurrent or total cost, nor did it describe the assumed promotion intervention and handwashing facility or consider alternatives to them.What are the new findings?The total economic cost over 10 years is US$ 12.2 – 15.3 billion, of which $4.9 – 6.6 billion (42%) is for behaviour change promotion interventions.The remainder is for facilities and supplies, with soap the biggest cost category (36%) followed by handwashing facilities (13%) and water (9%).The facility and supply costs per household comprise an initial investment in a handwashing facility (lasting 5 years) at a median of US$ 17, accompanied by an annual cost of $17 for soap and $5 for water.What do the new findings imply?The annual cost of behaviour change promotion to those with no handwashing facility represents 4.7% of median government health expenditure in LDCs.On top of this, investments in infrastructure and supplies are required. Soap in particular is a substantial and recurrent cost, which may be unaffordable for the poorest households.Promotion costs could be covered by mobilising resources from across government and partners, and could be reduced by harnessing economies of scale and integrating hand hygiene with other behaviour change campaigns where appropriate.Competing Interest StatementA portion of Dr Dreibelbis's salary is supported through an unrestricted donation to LSHTM by Reckitt, exclusive of the work on this manuscript.Funding StatementThis work was funded by the World Health Organisation (with support from the Governments of Japan, United Kingdom and Netherlands) and UNICEFAuthor DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:Ethical approval was not required because the study analysed secondary data from published studies.All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesQuantity data are derived from public domain resources (http://washdata.org/). Price data are derived from published studies referenced in the manuscript. The economic model combining quantities and prices into cost estimates is available on request from the authors. http://WASHdata.org